Trace organics in arizona surface and wastewaters

ACS Symposium Series

Volumn 1048, Issue , 2010, Pages 81-117

  Chiu, C ^a   Westerhoff, P K ^a  

^a Arizona State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; DRUG PRODUCTS; EFFLUENTS; MASS SPECTROMETRY; SUGAR SUBSTITUTES; SURFACE WATERS; WATER MANAGEMENT; WATER SUPPLY; WATERWORKS;

ARTIFICIAL SWEETENERS; DRINKING WATER SYSTEMS; ENDOCRINE DISRUPTING COMPOUND; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; TRACE ORGANIC COMPOUNDS; WASTEWATER TREATMENT PLANTS; WATERRESOURCE MANAGEMENT;

RECHARGING (UNDERGROUND WATERS);

EID: 84896029449     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2010-1048.ch004     Document Type: Conference Paper

References (60)

1. Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 2002, 36, 1202-1211.
2. Ternes, T. A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32, 3245-3260.
3. Snyder, S. A.; Westerhoff, P.; Yoon, Y.; Sedlak, D. L. Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for water treatment. Environ. Eng. Sci. 2003, 20, 449-469.
4. Daughton, C. H.; Ternes, T. A. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspect. 1999, 107, 907-938.
5. Ongerth, J. E.; Khan, S. Drug Residuals: How xenobiotics can affect water supply sources. J. Am. Water Works Assoc. 2004, 96, 94-101.
6. Weyer, P.; Riley, D. Endocrine Disruptors and Pharmaceuticals in Drinking Water; American Water Works Association Research Foundation, Denver, CO, 2001.
7. Warren, R.; Walker, B.; Nathan, V. R. Environmental factors influencing public health and medicine: Policy implications. J. Natl. Med. Assoc. 2002, 94, 185-193.
8. Foster, P. M. D.; McIntyre, B. S. Endocrine active agents: Implications of adverse and non-adverse changes. Toxicol. Pathol. 2002, 30, 59-65.
9. Mantovani, A.; Macri, A. Endocrine effects in the hazard assessment of drugs used in animal production. J. Exp. Clin. Cancer Res. 2002, 21, 445-456.
10. Ankley, G.; Mihaich, E.; Stahl, R.; Tillitt, D.; Colborn, T.; McMaster, S.; Miller, R.; Bantle, J.; Campbell, P.; Denslow, N.; Dickerson, R.; Folmar, L.; Fry, M.; Giesy, J.; Gray, L. E.; Guiney, P.; Hutchinson, T.; Kennedy, S.; Kramer, V.; LeBlanc, G.; Mayes, M.; Nimrod, A.; Patino, R.; Peterson, R.; Purdy, R.; Ringer, R.; Thomas, P.; Touart, L.; Van der Kraak, G.; Zacharewski, T. Overview of a workshop on screening methods for detecting potential (anti-)estrogenic/androgenic chemicals in wildlife. Environ. Toxicol. Chem. 1998, 17, 68-87.
11. Daston, G. P.; Cook, J. C.; Kavlock, R. J. Uncertainties for endocrine disrupters: Our view on progress. Toxicol. Sci. 2003, 74, 245-252.
12. Snyder, S. A.; Vanderford, B. J.; Pearson, R. A.; Quinones, O.; Yoon, Y. Analytical methods used to measure endocrine disrupting compounds in water. Pract. Period. Hazard., Toxic, Radioact. Waste Manage. 2003, 7, 224-234.
13. Zhang, T. C.; Emary, S. C. Jar tests for evaluation of atrazine removal at drinking water treatment plants. Environ. Eng. Sci. 1999, 16, 417-432.
14. Cunningham, V. L.; Binks, S. P.; Olson, M. J. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regul. Toxicol. Pharmacol. 2009, 53 (1), 39-45.
15. Munoz, I.; Gomez, M. J.; Molina-Diaz, A.; Huijbregts, M. A. J.; Fernandez-Alba, A. R.; Garcia-Calvo, E. Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. Chemosphere 2008, 74 (1), 37-44.
16. Kotchen, M.; Kallaos, J.; Wheeler, K.; Wong, C.; Zahller, M. Pharmaceuticals in wastewater: Behavior, preferences, and willingness to pay for a disposal program. J. Environ. Manage. 2009, 90 (3), 1476-1482.
17. Petrovic, M.; Eljarrat, E.; de Alda, M. J. L.; Barcelo, D. Endocrine disrupting compounds and other emerging contaminants in the environment: A survey on new monitoring strategies and occurrence data. Anal. Bioanal. Chem. 2004, 378 (3), 549-562.
18. Bendz, D.; Paxeus, N. A.; Ginn, T. R.; Loge, F. J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J. Hazard. Mater. 2005, 122 (3), 195-204.
19. Bester, K.; Huaffmeyer, N.; Schaub, E.; Klasmeier, J. D. Surface water concentrations of the fragrance compound OTNE in Germany: A comparison between data from measurements and models. Chemosphere 2008, 73 (8), 1366-1372.
20. Kasprzyk-Hordern, B.; Dinsdale, R. M.; Guwy, A. J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43 (2), 363-380.
21. Kuster, M.; de Alda, M. J.; Hernando, M. D.; Petrovic, M.; Martin-Alonso, J.; Barcelo, D. Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). J. Hydrol. 2008, 358 (1-2), 112-123.
22. Bartelt-Hunt, S. L.; Snow, D. D.; Damon, T.; Shockley, J.; Hoagland, K. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. Environ. Pollut. 2009, 157 (3), 786-791.
23. Zhang, X. L.; Yao, Y.; Zeng, X. Y.; Qian, G. R.; Guo, Y. W.; Wu, M. H.; Sheng, G. Y.; Fu, J. M. Synthetic musks in the aquatic environment and personal care products in Shanghai, China. Chemosphere 2008, 72 (10), 1553-1558.
24. Zhou, J. L.; Zhang, Z. L.; Banks, E.; Grover, D.; Jiang, J. Q. Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J. Hazard. Mater. 2009, 166 (2-3), 655-661.
25. Focazio, M. J.; Kolpin, D. W.; Barnes, K. K.; Furlong, E. T.; Meyer, M. T.; Zaugg, S. D.; Barber, L. B.; Thurman, M. E. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States. II. Untreated drinking water sources. Sci. Total Environ. 2008, 402 (2-3), 201-216.
26. Barnes, K. K.; Kolpin, D. W.; Furlong, E. T.; Zaugg, S. D.; Meyer, M. T.; Barber, L. B. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States. I. Groundwater. Sci. Total Environ. 2008, 402 (2-3), 192-200.
27. Farre, M.; Perez, S.; Kantiani, L.; Barcelo, D. Fate and toxicity of emerging pollutants, their metabolites and transformation products in aquatic environment. TrAC, Trends Anal. Chem. 2008, 27, 991.
28. Lin, A. Y. C.; Yu, T. H.; Lin, C. F. Pharmaceutical contamination in residential, industrial, and agricultural waste streams: Risk to aqueous environments in Taiwan. Chemosphere 2008, 74 (1), 131-141.
29. Benotti, M. J.; Brownawell, B. J. Microbial degradation of pharmaceuticals in estuarine and coastal seawater. Environ. Pollut. 2009, 157 (3), 994-1002.
30. Adams, C.; Wang, Y.; Loftin, K.; Meyer, M. Removal of antibiotics from surface and distilled water in conventional water treatment processes. J. Environ. Eng. Div. (Am. Soc. Civ. Eng.) 2002, 128, 253-260.
31. Petrovic, M.; Eljarrat, E.; de Alda, M. J. L.; Barcelo, D. Analysis and environmental levels of endocrine-disrupting compounds in freshwater sediments. TrAC, Trends Anal. Chem. 2001, 20, 637-648.
32. Ternes, T. A.; Meisenheimer, M.; McDowell, D.; Sacher, F.; Brauch, H. J.; Gulde, B. H.; Preuss, G.; Wilme, U.; Seibert, N. Z. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 2002, 36, 3855-3863.
33. Alum, A.; Yoon, Y.; Westerhoff, P.; Abbaszadegan, M. Oxidation of bisphenol A, 17b-estradiol, and 17a-ethynyl estradiol and byproduct estrogenicity. Environ. Toxicol. 2004, 19, 257-264.
34. Hu, J. Y.; Aizawa, T.; Ookubo, S. Products of aqueous chlorination of bisphenol A and their estrogenic activity. Environ. Sci. Technol. 2002, 36, 1980-1987.
35. Hu, J. Y.; Cheng, S. J.; Aizawa, T.; Terao, Y.; Kunikane, S. Products of aqueous chlorination of 17 beta-estradiol and their estrogenic activities. Environ. Sci. Technol. 2003, 37, 5665-5670.
36. Huber, M.; Canonica, S.; von Gunten, U. Oxidative Treatment of Pharmaceuticals in Drinking Waters; AWWA EDC Workshop, Cincinnati, OH, 2002.
37. Huber, M. M.; Canonica, S.; Park, G. Y.; Von Gunten, U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 2003, 37, 1016-1024.
38. Lee, B. C.; Kamata, M.; Akatsuka, Y.; Takeda, M.; Ohno, K.; Kamei, T.; Magara, Y. Effects of chlorine on the decrease of estrogenic chemicals. Water Res. 2004, 38, 733-739.
39. Lopez, A.; Mascolo, G.; Tiravanti, G.; Passino, R. Degradation of herbicides (ametryn and isoproturon) during water disinfection by means of two oxidants (hypochlorite and chlorine dioxide). Water Sci. Technol. 1997, 35, 129-136.
40. Pinkston, K. E.; Sedlak, D. L. Transformation of aromatic ether and amine containing pharmaceuticals during chlorine disinfection. Environ. Sci. Technol. 2004, 38, 4019-4025.
41. Von Gunten, U. Ozonation of drinking water: Part I. Oxidation kinetics and product formation. Water Res. 2003, 37, 1443-1467.
42. Zwiener, C.; Frimmel, F. H. Oxidative treatment of pharmaceuticals in water. Water Res. 2000, 34, 1881-1885.
43. Eldib, M. A.; Aly, O. A. Removal of phenylamide pesticides from drinking waters. 1. Effect of chemical coagulation and oxidants. Water Res. 1977, 11, 611-616.
44. Montiel, A.; Welte, B. Alternative options for atrazine: Incidence on water treatment device. Water Sci. Technol. 1992, 25, 103-110.
45. Crittenden, J. C.; Sanongraj, S.; Bulloch, J. L.; Hand, D. W.; Rogers, T. N.; Speth, T. F.; Ulmer, M. Correlation of aqueous-phase adsorption isotherms. Environ. Sci. Technol. 1999, 33, 2926-2933.
46. Bruce, D.; Westerhoff, P.; Brawley-Chesworth, A. Removal of 2-methylisoborneol and geosmin in surface water treatment plants in Arizona. J. Water Supply: Res Technol.-AQUA 2002, 51, 183-197.
47. Boyd, G. R.; Reemtsma, H.; Grimm, D. A.; Mitra, S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA, and Ontario, Canada. Sci. Total Environ. 2003, 311, 135-149.
48. Acero, J. L.; Von Gunten, U. Characterization of oxidation processes: Ozonation and the AOP O-3/H2O2. J. Am. Water Work Assoc. 2001, 93, 90-100.
49. Carlile, P.; Fielding, M.; Harding, L.; Hart, J.; Hutchison, J.; Kanda, R. Effect of Water Treatment Processes on Oestrogenic Chemicals; UKWIR Report 96/DW/05/01; UK Water Industry Research: London, 1996.
50. Haag, W. R.; Yao, C. C. D. Rate constants for reaction of hydroxyl radicals with several drinking-water contaminants. Environ. Sci. Technol. 1992, 26, 1005-1013.
51. Buxton, G. V.; Greenstock, C. L.; Helman, W. P.; Ross, A. B. Critical review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals (OH/O-) in aqueous solution. J. Phys. Ref. Data 1988, 17, 513-851.
52. Acero, J. L.; Stemmler, K.; Von Gunten, U. Degradation kinetics of atrazine and its degradation products with ozone and OH radicals: A predictive tool for drinking water treatment. Environ. Sci. Technol. 2000, 34, 591-597.
53. Rosario-Ortiz, F. L.; Snyder, S. A.; Suffet, I. H. Characterization of dissolved organic matter in drinking water sources impacted by multiple tributaries. Water Res. 2007, 41 (18), 4115-4128.
54. Brian, J. V.; Harris, C. A.; Scholze, M.; Backhaus, T.; Booy, P.; Lamoree, M.; Pojana, G.; Jonkers, N.; Runnalls, T.; Bonfa, A.; Marcomini, A.; Sumpter, J. P. Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals. Environ. Health Perspect. 2005, 113 (6), 721-728.
55. Benotti, M. J.; Trenholm, R. A.; Vanderford, B. J.; Holady, J. C.; Stanford, B. D.; Snyder, S. A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ. Sci. Technol. 2009, 43 (3), 597-603.
56. Hannah, R.; Daco, V. J.; Anderson, P. D.; Buzby, M. E.; Caldwell, D. J.; Cunningham, V. L.; Ericson, J. F.; Johnson, A. C.; Parke, N. J.; Samuelian, J. H.; Sumpter, J. P. Exposure assessment of 17 alpha-ethinylestradiol in surface waters of the United States and Europe. Environ. Toxicol. Chem. 2009, 28 (12), 2725-2732.
57. Buerge, I. J.; Buser, H. R.; Kahle, M.; Muller, M. D.; Poiger, T. Ubiquitous occurrence of the artificial sweetener acesulfame in the aquatic environment: an ideal chemical marker of domestic wastewater in groundwater. Environ. Sci. Technol. 2009, 43 (12), 4381-4385.
58. Caldwell, D. J.; Mastrocco, F.; Nowak, E.; Johnston, J.; Yekel, H.; Pfeiffer, D.; Hoyt, M.; DuPlessie, B. M.; Anderson, P. D. An assessment of potential exposure and risk from estrogens in drinking water. Environ. Health Perspect. 2010, 118 (3), 338-344.
59. Westerhoff, P.; Yoon, Y.; Snyder, S.; Wert, E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005, 39 (17), 6649-6663.
60. Heidler, J.; Halden, R. U. Meta-analysis of mass balances examining chemical fate during wastewater treatment. Environ. Sci. Technol. 2008, 42 (17), 6324-6332.